Stem Cell Therapy
Stem Cell Therapy Side Effects Reported in Clinical Studies
Stem Cell Malaysia· 7 min read
Stem cell therapy is often described online as "natural" and "safe because it uses your own cells". The reality is more nuanced. Like any medical intervention, cell-based treatments can cause side effects, and the risk depends heavily on the cell type, how it is processed, how it is delivered and who performs the procedure.
This guide summarises what has been reported in clinical studies and case reports, focusing on information that matters to patients in Malaysia who are weighing their options.
Why Safety Data Look Different Across Studies
When you read that a stem cell treatment is "safe", ask: safe compared with what, in whom and in which setting? Safety findings from a regulated phase II trial with sterile laboratories, trained investigators and careful follow-up cannot be assumed to apply to an unregulated clinic using unstandardised products.
Several factors shape the risk profile:
- Cell source. Bone marrow, fat, umbilical cord, placenta, embryonic or induced pluripotent cells each carry different considerations.
- Cell processing. Simple same-day concentration differs from weeks of laboratory culture.
- Route of delivery. Intra-articular, intravenous, intrathecal, intra-arterial or surgical implantation each have their own risks.
- Patient health. Age, immune status, infections and underlying disease matter.
- Regulatory oversight. Quality control, sterility testing and monitoring reduce risk.
Common, Usually Mild Side Effects
Systematic reviews of mesenchymal stem cell (MSC) studies, including a well-known safety review, have found that many trials report no increase in serious problems such as infection, death or malignancy, but a higher rate of transient fever. Commonly reported effects include:
| Side effect | Typical timing | Notes |
|---|---|---|
| Pain, swelling or stiffness at injection site | Hours to days | Frequent in joint injections |
| Low-grade fever | Within 24 to 48 hours | Often short-lived; the most consistently reported effect after intravenous MSCs |
| Headache | Hours to days | More common after lumbar puncture or intrathecal delivery |
| Fatigue or flu-like symptoms | 1 to 3 days | Usually settles without treatment |
| Bruising or soreness at harvest site | Days | After bone marrow aspiration or liposuction |
| Nausea | Hours | Sometimes related to sedation or infusion |
These effects are usually manageable, but they should be reported to your doctor, especially if they persist or worsen.
Less Common but Important Risks
Infection
Any procedure that breaks the skin can introduce germs. Contaminated cell products are a more serious concern. Reports have described joint infections and other complications after injection of inadequately processed or non-sterile products, including several cases documented in the United States linked to unapproved allograft suspensions.
Immune reactions
Allogeneic products can trigger allergic or immune responses in some people. Reactions may include rash, hives, fever, or, rarely, more severe responses. Donor screening and proper processing reduce risk. To understand how donor and self-derived cells differ, read our comparison of autologous versus allogeneic stem cells.
Blood clots and embolism
Some studies have raised concerns about intravenous cell infusions, particularly large cells or high doses, causing small clots or transient blockages in the lung's small vessels. Careful dosing and monitoring are important, and patients with clotting risks need special assessment.
Procedural complications
- Bleeding or haematoma at the harvest site
- Nerve irritation or damage
- Reactions to sedation or local anaesthetic
- Spinal complications after lumbar puncture, including headache, infection and bleeding
- Complications from surgical implantation into the brain or heart, which are higher-risk procedures
Unwanted tissue growth
There have been rare reports of abnormal tissue growth after inadequately regulated cell treatments. One widely cited case involved a patient in Asia who developed a spinal mass after receiving cell injections abroad, and another described kidney-related lesions after unproven treatment. These reports do not mean that all stem cell therapy causes tumours, and large reviews of MSC trials have generally not shown increased cancer rates, but they highlight why oversight and long follow-up matter.
Serious harm from unregulated procedures
One of the best-known examples involved patients who developed severe vision loss after fat-derived cells were injected into their eyes at a clinic offering unproven treatment. These cases underline that the site and method of injection matter enormously.
Risks Specific to Different Conditions
| Use | Particular safety considerations |
|---|---|
| Knee and joint injections | Pain flare, swelling, infection; see what stem cell evidence shows for knee osteoarthritis |
| Stroke and neurological conditions | Procedure-related risks of intrathecal or intracerebral delivery; see stem cell therapy for stroke recovery in Malaysia |
| Autism and paediatric use | Sedation, lumbar puncture and unknown long-term effects; see what research says about stem cell therapy for autism |
| Autoimmune disease | Infection risk if immunosuppressants are used; see stem cell therapy for rheumatoid arthritis and lupus |
| Heart conditions | Arrhythmia and procedural risks with catheter or surgical delivery; see stem cell therapy for heart failure |
Haematopoietic stem cell transplantation, used for certain blood cancers and autoimmune disorders, carries far higher risks such as severe infection and graft-versus-host disease. It is a specialist hospital procedure that should not be compared with a simple clinic injection.
Who Should Be Extra Cautious?
People who should discuss risks in detail with their doctor before any stem cell procedure include those who:
- Have active or recent cancer
- Have a known immune deficiency or take immunosuppressive drugs
- Have bleeding disorders or take blood thinners
- Have an active infection
- Are pregnant or breastfeeding
- Have significant heart, lung, liver or kidney disease
- Are children or adolescents
The Malaysian Perspective
In Malaysia, patients are protected by a framework in which cell and gene therapy products are regulated by the National Pharmaceutical Regulatory Agency (NPRA) and clinics must follow Ministry of Health requirements, but practices can still vary between providers. Ask for evidence of registration, laboratory standards and adverse event procedures. Our guide to Malaysian NPRA rules on cell and gene therapy products explains what documentation to request.
If you travel between Kuala Lumpur, Penang, Johor Bahru or abroad for treatment, consider:
- Continuity of care. Who will manage complications when you return home?
- Emergency access. Is there a hospital with intensive care facilities nearby?
- Records. Do you receive a full report of the product, dose and procedure?
- Travel risks. Long flights after an infusion can raise clot risk in vulnerable people.
Red Flags Suggesting Higher Risk
- Cell products prepared in non-medical premises
- Same-day "cultured" cell claims, since culture takes time
- Lack of sterility or infection screening tests
- Refusal to share product source or laboratory details
- Injection of cells into locations without medical justification
- No informed consent form or vague risk information
- Multiple different routes offered at once, such as intravenous plus intrathecal plus local injections, without clear rationale
What to Ask Before Treatment
- What risks have been reported for this exact product and condition?
- How will you manage infection, allergic reaction or clot complications?
- Who will follow me up, and for how long?
- Will you report adverse events to the regulator?
- What happens if I need emergency care?
- How many sessions do you recommend, and how does that change the risk? See how many stem cell sessions are usually needed.
After Treatment: When to Seek Medical Help
Contact a doctor promptly if you develop:
- Fever lasting more than 48 hours or above 38.5 degrees Celsius
- Increasing pain, redness, heat or swelling at the injection site
- Shortness of breath, chest pain or sudden leg swelling
- Severe headache, neck stiffness or neurological changes
- Rash, facial swelling or breathing difficulty
- Unusual lumps or new symptoms weeks or months later
In Malaysia, go to the nearest emergency department for severe symptoms and bring your treatment documents.
Frequently Asked Questions
Are stem cell side effects usually serious?
Most reported effects in regulated studies are mild and temporary, but serious events can occur, especially with contaminated or inappropriate products.
Is using my own cells risk-free?
No. Harvest procedures, processing and injection can all cause complications.
Can stem cells cause cancer?
Large reviews of MSC trials have not shown clear increases in cancer, but long-term data are limited and unregulated products pose additional uncertainty.
Should side effects be reported?
Yes. Reporting helps improve safety monitoring. Ask your doctor or the regulator how adverse events are recorded.
Conclusion
Stem cell therapy is neither uniformly dangerous nor automatically safe. Regulated studies show that many treatments are tolerated reasonably well, with fever, soreness and short-term reactions the most common effects. Yet serious harm has occurred, mostly linked to poor manufacturing, inappropriate delivery or lack of oversight. Insist on transparency, proper documentation and a clear plan for follow-up.
This article is for general information and is not medical advice. Speak to a licensed practitioner about your individual risks.
